Sufang Y. Chu

209 Tongshan Road
Xuzhou, 221004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Microprotein MP104 Promotes Malignant Progression of Colorectal Cancer Through Regulating Protein Translation.

Microprotein MP104 Promotes Malignant Progression of Colorectal Cancer Through Regulating Protein Translation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 16, 2026

TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2.

TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2.

Journal: Cell death discovery

Published: April 16, 2025

PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression.

PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression.

Journal: Research (Washington, D.C.)

Published: September 29, 2024

A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer.

A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer.

Journal: Journal of translational medicine

Published: September 19, 2024

Correction: DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer.

Correction: DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer.

Journal: British journal of cancer

Published: July 17, 2024

TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression.

TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression.

Journal: Cell death & disease

Published: June 02, 2024

Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis.

Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis.

Journal: iScience

Published: September 11, 2023

FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation.

FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation.

Journal: Cell death discovery

Published: August 24, 2023

Correction: Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9.

Correction: Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9.

Journal: Cell death discovery

Published: August 21, 2023

circEPB41L2 blocks the progression and metastasis in non-small cell lung cancer by promoting TRIP12-triggered PTBP1 ubiquitylation.

circEPB41L2 blocks the progression and metastasis in non-small cell lung cancer by promoting TRIP12-triggered PTBP1 ubiquitylation.

Journal: Cell death discovery

Published: July 18, 2023

Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma.

Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma.

Journal: Cell death & disease

Published: July 05, 2023

Correction to: The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.

Correction to: The kinesin motor protein KIF4A as a potential therapeutic target in renal cell carcinoma.

Journal: Investigational new drugs

Published: May 26, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026